News Update

Update, 29.4.2024

Octapharma wishes to update our stakeholders regarding the recent event affecting our plasma donation centers in the USA.

Thanks to the efforts of our Octapharma Plasma USA and Global IT teams, all our plasma donation centers in the USA have been fully operational again since April 25. Our production sites were not impacted by this event, and we have been able to maintain our normal production schedules of our life-saving therapies as planned.

Octapharma was founded in 1983 with the aims of bringing new innovations to the plasma fractionation industry, and manufacturing a higher quality, virally safe FVIII concentrate for hemophilia A patients. Since our founding in 1983, we have grown to provide our life-saving therapies to millions of patients around the world who are dependent on plasma derived therapies to live a normal life.

Octapharma remains committed to safeguarding the information of our donors, employees, and other stakeholders. Octapharma is committed to the highest levels of integrity and ethical conduct, and we will continue to live these values in the future. Compliance with applicable data protection law, such as the European and US data protection laws and regulations, and their equivalent frameworks in other countries where we operate, remains one of our highest priorities.  

We continue to investigate this event in consultation with outside experts and the relevant authorities, and will provide further updates as appropriate.  

Update, 25.4.2024

Octapharma Plasma USA is pleased to announce that all 176 plasma donation centres across the country have now re-opened and resumed normal operations.  

Our plasma donation centres in Germany continue to operate as normal.  

Our European production sites continue to maintain normal production operations as planned. 

Update, 19.4.2024

On Wednesday, April 17, Octapharma Plasma USA detected suspicious activity on its network. We activated our incident response processes to investigate and also took systems offline to limit the potential scope of this event. 

Our staff are working tirelessly to reopen our USA plasma donation centres as soon as possible. Further information in this regard will be updated on Octapharma Plasma’s website www.octapharmaplasma.com as it becomes available.

Our plasma donation centres in Germany have not been impacted to date and continue to operate as normal.

Our European production sites have not been impacted to date, and we have been able to maintain our production operations as planned.